United Imaging Intelligence presents next-generation radiology solutions at ECR 2024
Saturday, March 02, 2024
At the European Congress of Radiology (ECR) 2024 in Vienna , United Imaging Intelligence (UII), a subsidiary of United Imaging Group, proudly presented its latest advances in medical AI technology. Known for its AI-driven applications in healthcare, UII's presentation at ECR 2024 represents a significant step towards "Next Generation Radiology" and showcases intelligent healthcare solutions in line with the congress's forward-looking theme.
Groundbreaking AI applications for large medical image models and surgical planning
Amid the rapid change in the medical technology landscape driven by basic models, the UII is adopting these critical frameworks to improve "Next Generation Radiology". An important aspect of this progress is AI research in the field of medical imaging. At ECR 2024, the UII introduced uAI SAT, an innovative AI-driven annotation tool hosted on its biomedical research platform. By using a large medical image model, uAI SAT improves intelligent interactive segmentation, reducing annotation times from hours to just minutes, thereby contributing to the advancement of scientific research.
The uAI Pioneer Portal, UII's standout exhibit, captivated visitors with its advanced 3D pre-operative planning applications tailored for thoracic, hepatobiliary and urological surgeries. The outstanding feature of the portal is its one-click functionality for 3D reconstruction of lesions and organs at a diagnostic level. Combined with a gesture-controlled 3D monitor, this technology allows users to engage with virtual reality and manipulate detailed models through hand gestures without the need for 3D glasses or helmets. It provides clinicians with an immersive and intuitive visualization of a patient's preoperative plan and intraoperative anatomy.
Advanced clinical diagnostic innovations covering the full spectrum
The UII exhibition went beyond the presentation of technological innovations. A collection of clinical solutions for neurology, cardiology, chest and oncology were also presented. Among the many breakthroughs, CE certification for specific AI applications within UII's thoracic solutions, including uAI Discovery Pulmonary Nodules, uAI Discover Pneumonia and uAI Discover Fracture, underscores UII's commitment to healthcare innovation. With a single chest CT scan, the chest solution provides an assessment of more than ten common chest diseases, minimizing radiation exposure and waiting time for the patient.
In neurology, UII's AI solutions cover the entire continuum of stroke management, from acute care to research. Recognizing the importance of timely intervention in stroke treatment, UII has developed CT-based AI models that enable rapid and accurate stroke detection, thereby optimizing the treatment process. Significant progress has also been made in the development of MRI-assisted diagnostic models for brain diseases, improving treatment strategies and contributing to advances in neuroscience research.
According to the WHO, cardiovascular diseases are one of the most common causes of death worldwide, with an estimated 17.9 million deaths each year. UII's comprehensive cardiac imaging solutions have become indispensable. By integrating CT and MRI assessments, UII's cardiovascular solutions provide detailed analyzes of anatomical, functional and tissue characteristics that optimize image post-processing and significantly reduce the time required for diagnosis.
Finally, UII's commitment to oncology is also reflected in its comprehensive offering of applications for imaging, screening, diagnosis and treatment of a variety of cancers, including lung cancer, prostate cancer, breast cancer and metastatic disease.
UII strongly believes that medical AI is a critical catalyst that will lead radiology into a new era of transformation. Having deployed its innovative products in over 3,000 medical facilities worldwide and established research and product collaborations in Europe, UII remains true to its mission to further expand development and partnerships across the region to make the benefits of medical AI accessible to all make.
(Notes: Products and features mentioned herein may not be commercially available in all countries. Their future availability cannot be guaranteed.)
Source: prnewswire.com